See All Slides - tctmd.com

Slides

Presentation TCT 2024

TCT 279: Impacts of Hospital Volume and Patient-Hospital Distances on Outcomes of Patients Undergoing Percutaneous Microaxial Ventricular Assist Devices for Cardiogenic Shock

Presenter: Atsuyuki Watanabe

October 29, 2024

Presentation TCT 2024

TCT 785: Post-Procedural Patient-Reported Outcomes and Quality of Life Is Worse in Women Than Men Despite Similar Post-PCI VFFR Values

Presenter: Karol Sadowski

October 29, 2024

Presentation TCT 2024

TCT 255: Identifying Patients With Stable Ischemic Cardiomyopathy Whose LVEF Will Increase After PCI

Presenter: Stephen Ellis

October 29, 2024

Presentation TCT 2024

TCT 912: Impact of Implant Depth in Valve Hemodynamics of Balloon- and Self-Expanding Transcatheter Aortic Valves for Failed Small Surgical Aortic Bioprostheses: A Substudy of the LYTEN Trial

Presenter: Jorge Nuche

October 29, 2024

Presentation TCT 2024

TCT 911: Vascular Disease in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: From Incidence to Clinical Outcomes

Presenter: Gijs Broeze

October 29, 2024

Presentation TCT 2024

TCT 250: Temporal Trends in Ischemic Heart Disease-related Mortality in Canada Over the Past 3 Decades

Presenter: Ahmed Abdulelah

October 29, 2024

Presentation TCT 2024

TCT 497: Sex-Specific Clinical Outcomes After Treatment of In-Stent Restenosis With the AGENT Paclitaxel-Coated Balloon: A Subgroup Analysis of the AGENT IDE Randomized Trial

Presenter: Jennifer Tremmel

October 29, 2024

Presentation TCT 2024

TCT 1322: Neoatherosclerosis After Drug-Coated Balloon Treated In-Stent Restenosis

Presenter: Leonardo Sinnott Silva

October 29, 2024

Presentation TCT 2024

TCT 1501: Valve-in-Valve-in-Valve (Surgical Valve > Sapien 3 > Sapien 3 > Valve Fracture)

Presenter: PRASHANT AHLAWAT

October 29, 2024

Presentation TCT 2024

My Personal Guide to Management of Patients Returning Due to Target Vessel Failure

Presenter: Stuart Watkins

October 29, 2024

Advertisement

Slides

TCT 279: Impacts of Hospital Volume and Patient-Hospital Distances on Outcomes of Patients Undergoing Percutaneous Microaxial Ventricular Assist Devices for Cardiogenic Shock

TCT 785: Post-Procedural Patient-Reported Outcomes and Quality of Life Is Worse in Women Than Men Despite Similar Post-PCI VFFR Values

TCT 255: Identifying Patients With Stable Ischemic Cardiomyopathy Whose LVEF Will Increase After PCI

TCT 912: Impact of Implant Depth in Valve Hemodynamics of Balloon- and Self-Expanding Transcatheter Aortic Valves for Failed Small Surgical Aortic Bioprostheses: A Substudy of the LYTEN Trial

TCT 911: Vascular Disease in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: From Incidence to Clinical Outcomes

TCT 250: Temporal Trends in Ischemic Heart Disease-related Mortality in Canada Over the Past 3 Decades

TCT 497: Sex-Specific Clinical Outcomes After Treatment of In-Stent Restenosis With the AGENT Paclitaxel-Coated Balloon: A Subgroup Analysis of the AGENT IDE Randomized Trial

TCT 1322: Neoatherosclerosis After Drug-Coated Balloon Treated In-Stent Restenosis

TCT 1501: Valve-in-Valve-in-Valve (Surgical Valve > Sapien 3 > Sapien 3 > Valve Fracture)

My Personal Guide to Management of Patients Returning Due to Target Vessel Failure

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content